Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN® 550 Mg Tablets Non-C IBS Supplemental New Drug …
Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter on March 7, 2011 for the supplemental New Drug Application for XIFAXAN® 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating.
Read more on Business Wire via Yahoo! Finance
At 3M, A Struggle Between Efficiency And Creativity
Not too many years ago, the temple of management was General Electric ( GE ). Former CEO Jack Welch was the high priest, and his disciples spread the word to executive suites throughout the land.
Read more on BusinessWeek
Exalead Named to KMWorld “100 Companies that Matter” for Sixth Straight Year
SAN FRANCISCO, CA–(Marketwire – 03/08/11) – Dassault Systmes (Euronext Paris: #13065, DSY.PA), today announced that its subsidiary Exalead, a global provider of search-based applications (SBA) technology, has been named a KMWorld “100 Companies that Matter” for the sixth straight year. Exalead’s flagship search-based application platform, CloudView 360, enables enterprises to rapidly deploy …
Read more on Marketwire via Yahoo! Finance